HONG KONG( BLOOMBERG)-The vaccine made by Sinovac Biotech, one of the most widely used in the world, does not provide sufficient antibodies to neutralise the Omicron variant, said Hong Kong researchers in initial lab findings that may have sweeping consequences for the millions of people relying on the Chinese shot to protect them against Covid-19. Among a group of 25 people fully vaccinated with the Sinovac shot, none showed sufficient antibodies in their blood serum to neutralise Omicron, said
综合
海峡时报-亚洲
2021-12-15 00:00:00.0